Search

Purpose: The lifestyle of people throughout the world has been affected exceptionally due to the severity of COVID-19 pandemic disease. Different steps to prevent this pandemic disease have been taken to protect the entire nation by the government of the affected countries. Several research works are going on to forecast on the different cases of the disease like new affected cases, new death cases. But the researchers have not worked for the Stringency Index on which transmission of the virus mostly depends till now. Objective: Decision of maintaining strict lockdown and partial lockdown are the most effective preventive measure to resist this pandemic disease by breaking the cycle of transmission through social distancing. Methodology: In our proposed work we have introduced the reality. Data from various sources on this disease for most affected countries like India have been collected by the authors. They have started an experiment on that data and ultimately have prepared a mathematical model to correlate between basic reproduction rate and the stringency index. Results: The authors have calculated average new infected cases, maximum new infected cases and minimum new infected cases which are highly associated with the stringency index. Average death cases, maximum death cases, and minimum death cases are also been calculated as these are also associated with the stringency index. Conclusion: Depending on the result of experiment of our work government of India as well as World Health Organization can take a decision for maintaining an effective lockdown to protect the entire nation from this deadlier disease.

Supplemental material, sj-pdf-2-pul-10.1177_2045894020966889 for Risk factors for 30-day readmission in adults hospitalized for pulmonary hypertension by Priyanka T. Bhattacharya, Asif M. Abdul Hameed, Shubhadeep T. Bhattacharya, Julio A. Chirinos, Wei-Ting Hwang, Edo Y. Birati, Jonathan N. Menachem, Saurav Chatterjee, Jay S. Giri, Steven M. Kawut, Stephen E. Kimmel and Jeremy A. Mazurek in Pulmonary Circulation

Supplemental material, sj-pdf-2-pul-10.1177_2045894020966889 for Risk factors for 30-day readmission in adults hospitalized for pulmonary hypertension by Priyanka T. Bhattacharya, Asif M. Abdul Hameed, Shubhadeep T. Bhattacharya, Julio A. Chirinos, Wei-Ting Hwang, Edo Y. Birati, Jonathan N. Menachem, Saurav Chatterjee, Jay S. Giri, Steven M. Kawut, Stephen E. Kimmel and Jeremy A. Mazurek in Pulmonary Circulation

Supplemental material, sj-pdf-1-pul-10.1177_2045894020966889 for Risk factors for 30-day readmission in adults hospitalized for pulmonary hypertension by Priyanka T. Bhattacharya, Asif M. Abdul Hameed, Shubhadeep T. Bhattacharya, Julio A. Chirinos, Wei-Ting Hwang, Edo Y. Birati, Jonathan N. Menachem, Saurav Chatterjee, Jay S. Giri, Steven M. Kawut, Stephen E. Kimmel and Jeremy A. Mazurek in Pulmonary Circulation

Supplemental material, sj-pdf-1-pul-10.1177_2045894020966889 for Risk factors for 30-day readmission in adults hospitalized for pulmonary hypertension by Priyanka T. Bhattacharya, Asif M. Abdul Hameed, Shubhadeep T. Bhattacharya, Julio A. Chirinos, Wei-Ting Hwang, Edo Y. Birati, Jonathan N. Menachem, Saurav Chatterjee, Jay S. Giri, Steven M. Kawut, Stephen E. Kimmel and Jeremy A. Mazurek in Pulmonary Circulation

Human epidermal growth factor receptor 2 (HER2)-positive is an aggressive subtype of breast cancer and has historically been associated with poor outcomes. The availability of various anti-HER2 therapies, including trastuzumab, lapatinib, pertuzumab, and trastuzumab emtansine (TDM-1), has remarkably improved the clinical outcomes in patients with HER2-positive metastatic breast cancer (mBC). However, there is a need to optimize treatment within this population, given the wide variability in clinical presentation. Additionally, geographical and socio-economic considerations too need to be taken into account. To clarify and collate evidence pertaining to HER2-positive metastatic breast cancer, a panel of medical and clinical oncologists from across India developed representative clinical scenarios commonly encountered in clinical practice in the country. This was followed by two meetings wherein each clinical scenario was discussed in detail and relevant evidence appraised. The result of this process is presented in this manuscript as evidence followed by therapeutic recommendations of this panel for management of HER2-positive mBC in the Indian population.

Supplemental material, Supplemental Material1 for Right ventricular outflow tract velocity time integral-to-pulmonary artery systolic pressure ratio: a non-invasive metric of pulmonary arterial compliance differs across the spectrum of pulmonary hypertension by Priyanka T. Bhattacharya, Gregory S. Troutman, Frances Mao, Arieh L. Fox, Monique S. Tanna, Payman Zamani, E. Wilson Grandin, Jonathan N. Menachem, Edo Y. Birati, Julio A. Chirinos, Sula Mazimba, Kerri Akaya Smith, Steven M. Kawut, Paul R. Forfia, Anjali Vaidya and Jeremy A. Mazurek in Pulmonary Circulation

Supplemental material, Supplemental Material2 for Right ventricular outflow tract velocity time integral-to-pulmonary artery systolic pressure ratio: a non-invasive metric of pulmonary arterial compliance differs across the spectrum of pulmonary hypertension by Priyanka T. Bhattacharya, Gregory S. Troutman, Frances Mao, Arieh L. Fox, Monique S. Tanna, Payman Zamani, E. Wilson Grandin, Jonathan N. Menachem, Edo Y. Birati, Julio A. Chirinos, Sula Mazimba, Kerri Akaya Smith, Steven M. Kawut, Paul R. Forfia, Anjali Vaidya and Jeremy A. Mazurek in Pulmonary Circulation

Supplemental material, Supplemental Material3 for Right ventricular outflow tract velocity time integral-to-pulmonary artery systolic pressure ratio: a non-invasive metric of pulmonary arterial compliance differs across the spectrum of pulmonary hypertension by Priyanka T. Bhattacharya, Gregory S. Troutman, Frances Mao, Arieh L. Fox, Monique S. Tanna, Payman Zamani, E. Wilson Grandin, Jonathan N. Menachem, Edo Y. Birati, Julio A. Chirinos, Sula Mazimba, Kerri Akaya Smith, Steven M. Kawut, Paul R. Forfia, Anjali Vaidya and Jeremy A. Mazurek in Pulmonary Circulation